144 related articles for article (PubMed ID: 38105358)
1. Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters.
Salachan PV; Ulhøi BP; Borre M; Sørensen KD
Sci Rep; 2023 Dec; 13(1):22445. PubMed ID: 38105358
[TBL] [Abstract][Full Text] [Related]
2. Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
Ebrahimizadeh W; Guérard KP; Rouzbeh S; Bramhecha YM; Scarlata E; Brimo F; Patel PG; Jamaspishvili T; Aprikian AG; Berman D; Bartlett JMS; Chevalier S; Lapointe J
J Mol Diagn; 2020 Oct; 22(10):1246-1263. PubMed ID: 32763409
[TBL] [Abstract][Full Text] [Related]
3. Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
Gunn SR; Govender S; Sims CL; Khurana A; Koo S; Scoggin J; Moore MW; Cotter PD
J Mol Diagn; 2018 May; 20(3):279-288. PubMed ID: 29471114
[TBL] [Abstract][Full Text] [Related]
4. Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
Robbe P; Popitsch N; Knight SJL; Antoniou P; Becq J; He M; Kanapin A; Samsonova A; Vavoulis DV; Ross MT; Kingsbury Z; Cabes M; Ramos SDC; Page S; Dreau H; Ridout K; Jones LJ; Tuff-Lacey A; Henderson S; Mason J; Buffa FM; Verrill C; Maldonado-Perez D; Roxanis I; Collantes E; Browning L; Dhar S; Damato S; Davies S; Caulfield M; Bentley DR; Taylor JC; Turnbull C; Schuh A;
Genet Med; 2018 Oct; 20(10):1196-1205. PubMed ID: 29388947
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
[TBL] [Abstract][Full Text] [Related]
6. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
[TBL] [Abstract][Full Text] [Related]
7. Genetic markers associated with early cancer-specific mortality following prostatectomy.
Liu W; Xie CC; Thomas CY; Kim ST; Lindberg J; Egevad L; Wang Z; Zhang Z; Sun J; Sun J; Koty PP; Kader AK; Cramer SD; Bova GS; Zheng SL; Grönberg H; Isaacs WB; Xu J
Cancer; 2013 Jul; 119(13):2405-12. PubMed ID: 23609948
[TBL] [Abstract][Full Text] [Related]
8. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer.
Ren T; Suo J; Liu S; Wang S; Shu S; Xiang Y; Lang JH
J Gynecol Oncol; 2018 Sep; 29(5):e78. PubMed ID: 30022638
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis.
Hosein AN; Song S; McCart Reed AE; Jayanthan J; Reid LE; Kutasovic JR; Cummings MC; Waddell N; Lakhani SR; Chenevix-Trench G; Simpson PT
Lab Invest; 2013 Jun; 93(6):701-10. PubMed ID: 23568031
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
12. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
Williams JL; Greer PA; Squire JA
Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
[TBL] [Abstract][Full Text] [Related]
13. Copy number alterations are associated with metastatic-lethal progression in prostate cancer.
Wang X; Grasso CS; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Troyer DA; Lance R; Feng Z; Dai JY; Stanford JL
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):494-506. PubMed ID: 32071439
[TBL] [Abstract][Full Text] [Related]
14. Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue.
Kader T; Goode DL; Wong SQ; Connaughton J; Rowley SM; Devereux L; Byrne D; Fox SB; Mir Arnau G; Tothill RW; Campbell IG; Gorringe KL
Genome Med; 2016 Nov; 8(1):121. PubMed ID: 27846907
[TBL] [Abstract][Full Text] [Related]
15. Copy number alterations in prostate tumors and disease aggressiveness.
Cheng I; Levin AM; Tai YC; Plummer S; Chen GK; Neslund-Dudas C; Casey G; Rybicki BA; Witte JS
Genes Chromosomes Cancer; 2012 Jan; 51(1):66-76. PubMed ID: 21965145
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J
Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894
[TBL] [Abstract][Full Text] [Related]
17. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
[TBL] [Abstract][Full Text] [Related]
18. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.
Kerick M; Isau M; Timmermann B; Sültmann H; Herwig R; Krobitsch S; Schaefer G; Verdorfer I; Bartsch G; Klocker H; Lehrach H; Schweiger MR
BMC Med Genomics; 2011 Sep; 4():68. PubMed ID: 21958464
[TBL] [Abstract][Full Text] [Related]
19. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma.
Han X; Tan Q; Yang S; Li J; Xu J; Hao X; Hu X; Xing P; Liu Y; Lin L; Gui L; Qin Y; Yang J; Liu P; Wang X; Dai W; Lin D; Lin H; Shi Y
Front Oncol; 2019; 9():556. PubMed ID: 31448219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
